Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA.
Seo DH, Hur W, Won J, Han JW, Yoon SK, Bae S, Kim KH, Sung PS.
Viruses. 2024 Dec 7;16(12):1890. doi: 10.3390/v16121890.
Chronic Hepatitis B Infection: New Approaches towards Cure.
Ogunnaike M, Das S, Raut SS, Sultana A, Nayan MU, Ganesan M, Edagwa BJ, Osna NA, Poluektova LY.
Biomolecules. 2023 Aug 1;13(8):1208. doi: 10.3390/biom13081208.
Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem.
Boora S, Sharma V, Kaushik S, Bhupatiraju AV, Singh S, Kaushik S.
Braz J Microbiol. 2023 Jun;54(2):679-689. doi: 10.1007/s42770-023-00970-y. Epub 2023 Apr 14.
Chronic hepatitis B infection and pre-eclampsia/eclampsia: a Mendelian randomisation study.
Pu R, Wang Z, Shang X, Lu J, Xu J, Xing Y.
J Obstet Gynaecol. 2025 Dec;45(1):2500972. doi: 10.1080/01443615.2025.2500972. Epub 2025 May 15.
Therapeutic vaccination for chronic hepatitis B.
Kosinska AD, Bauer T, Protzer U.
Curr Opin Virol. 2017 Apr;23:75-81. doi: 10.1016/j.coviro.2017.03.011. Epub 2017 Apr 25.
New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage.
Yin GQ, Li J, Zhong B, Yang YF, Wang MR.
World J Gastroenterol. 2021 Feb 28;27(8):666-676. doi: 10.3748/wjg.v27.i8.666.
Etiologies of Persistent Aminotransferase Elevations in Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogs.
Xiong QF, Zou L, Chen ZJ, Liu HL, Lu YJ, Liu DX, Yang YF.
Turk J Gastroenterol. 2024 Feb 29;35(6):497-504. doi: 10.5152/tjg.2024.23512.
Chronic hepatitis B virus persistence: Mechanisms, consequences and implications for achieving cure.
Georgi C, D'Souza S, Osiowy C, Coffin CS, Cooper CL.
Ann Hepatol. 2025 Jul-Dec;30(2):101938. doi: 10.1016/j.aohep.2025.101938. Epub 2025 Jun 26.
Immune suppression in chronic hepatitis B infection associated liver disease: A review.
Li TY, Yang Y, Zhou G, Tu ZK.
World J Gastroenterol. 2019 Jul 21;25(27):3527-3537. doi: 10.3748/wjg.v25.i27.3527.
Engineered therapeutic nanovaccine against chronic hepatitis B virus infection.
Qiao D, Chen Y, Liu L.
Biomaterials. 2021 Feb;269:120674. doi: 10.1016/j.biomaterials.2021.120674. Epub 2021 Jan 13.
